Insider Transactions last 24 months for Kyverna Therapeutics, Inc. - NSDQ: KYTX
| Transactions | |||
| All | Buy | Sell | Option Exercise |
Filer's Name |
Relationship/ Title |
Trans. Date |
Trans. Type |
Ownership Type |
Security Type |
Shares |
Price |
Trans. Value |
Total Shares Owned |
| Biddle Warner Weston | Chief Executive Officer | 03/13/2026 | AA | Direct | COM | 58,000 | $0.00 | $0.00 | 58,000 |
| Grasso Marc | Chief Financial Officer | 03/13/2026 | AA | Direct | COM | 10,000 | $0.00 | $0.00 | 10,000 |
| Gehchan Naji | See Remarks | 03/13/2026 | AA | Direct | COM | 18,000 | $0.00 | $0.00 | 18,000 |
| Emany Sravan Kumar | Director | 02/24/2026 | AA | Direct | COM | 11,006 | $0.00 | $0.00 | 11,006 |
| Miller Andrew Craig | Director | 02/24/2026 | AA | Direct | COM | 11,006 | $0.00 | $0.00 | 11,006 |
| Shaw Christi | Executive Chairperson | 01/12/2026 | AA | Direct | COM | 24,301 | $0.00 | $0.00 | 70,935 |
| Shaw Christi | Executive Chairperson | 01/12/2026 | AA | Direct | COM | 30,000 | $0.00 | $0.00 | 46,634 |
| Westlake Biopartners Opportunity Fund I, L.P. | Other | 12/18/2025 | AP | Indirect | COM | 133,333 | $7.50 | $999,997.50 | 869,317 |
| Seidenberg Beth C | Director | 12/18/2025 | AP | Indirect | COM | 133,333 | $7.50 | $999,997.50 | 869,317 |
| Walker Karen Marie | Chief Technology Officer | 12/15/2025 | DS | Direct | COM | 23,998 | $12.20 | $292,775.60 | 22,636 |
| Walker Karen Marie | Chief Technology Officer | 12/15/2025 | AM | Direct | COM | 23,998 | $4.83 | $115,910.34 | 46,634 |
| Cohen Fred E | Director | 05/29/2025 | AA | Direct | COM | 16,634 | $0.00 | $0.00 | 16,634 |
| Clark Ian T | Director | 05/29/2025 | AA | Direct | COM | 16,634 | $0.00 | $0.00 | 16,634 |
| Aktar Mert | Director | 05/29/2025 | AA | Direct | COM | 16,634 | $0.00 | $0.00 | 16,634 |
| Spiegelman Daniel K | Director | 05/29/2025 | AA | Direct | COM | 16,634 | $0.00 | $0.00 | 16,634 |
| Seidenberg Beth C | Director | 05/29/2025 | AA | Direct | COM | 16,634 | $0.00 | $0.00 | 16,634 |
| Shaw Christi | Director | 05/29/2025 | AA | Direct | COM | 16,634 | $0.00 | $0.00 | 16,634 |
| Walker Karen Marie | Chief Technology Officer | 04/11/2025 | AA | Direct | COM | 13,000 | $0.00 | $0.00 | 22,636 |
| Jones Ryan Alexander | Chief Financial Officer | 04/11/2025 | AA | Direct | COM | 12,000 | $0.00 | $0.00 | 55,950 |
| Walker Karen Marie | Chief Technology Officer | 06/06/2024 | AM | Direct | COM | 9,636 | $4.42 | $42,591.12 | 9,636 |
| Jones Ryan Alexander | Chief Financial Officer | 05/28/2024 | AM | Direct | COM | 7,146 | $0.73 | $5,216.58 | 43,950 |
| Jones Ryan Alexander | Chief Financial Officer | 05/28/2024 | AM | Direct | COM | 10,870 | $0.73 | $7,935.10 | 36,804 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel | |||||||
© 2000 - 2026 Zacks Investment Research